Is Minocycline a Solution for Multidrug-Resistant Acinetobacter Baumannii?

References

• Dijkshoorn L , NemecA , SeifertH . An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii . Nat. Rev. Microbiol.5 ( 12 ), 939 – 951 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Davis KA , MoranKA , McAllisterCK , Gray JP . Multidrug-resistant Acinetobacter extremity infections in soldiers . Emerg. Infect. Dis.11 ( 8 ), 1218 – 1224 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Johnson EN , BurnsTC , HaydaRA , HospenthalDR , MurrayCK . Infectious complications of open type III tibial fractures among combat casualties . Clin. Infect. Dis.45 ( 4 ), 409 – 415 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Neonakis IK , SpandidosDA , PetinakiE . Confronting multidrug-resistant Acinetobacter baumannii: a review . Int. J. Antimicrob. Agents37 ( 2 ), 102 – 109 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bishburg E , BishburgK . Minocycline – an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii . Int. J. Antimicrob. Agents34 ( 5 ), 395 – 401 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Wood GC , HanesSD , BoucherBA , CroceMA , FabianTC . Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia . Intensive Care Med.29 ( 11 ), 2072 – 2076 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Noah JW , DolanMA , BabinP , WollenzienP . Effects of tetracycline and spectinomycin on the tertiary structure of ribosomal RNA in the Escherichia coli 30 S ribosomal subunit . J. Biol. Chem.274 ( 23 ), 16576 – 16581 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Smith K , LeydenJJ . Safety of doxycycline and minocycline: a systematic review . Clin. Ther.27 ( 9 ), 1329 – 1342 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Saivin S , HouinG . Clinical pharmacokinetics of doxycycline and minocycline . Clin. Pharmacokinet.15 ( 6 ), 355 – 366 ( 1988 ).
   PubMed Web of Science ®Google Scholar
• Goulden V , GlassD , CunliffeWJ . Safety of long-term high-dose minocycline in the treatment of acne . Br. J. Dermatol.134 ( 4 ), 693 – 695 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Garner SE , EadyEA , PopescuC , NewtonJ , Li WA.  Minocycline for acne vulgaris: efficacy and safety Minocycline for acne vulgaris: efficacy and safety . Cochrane Database Syst. Rev.1 , CD002086 ( 2003 ).
   Google Scholar
• Washington JA 2nd , YuPK , MartinWJ . In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing . Appl. Microbiol.19 ( 2 ), 259 – 263 ( 1970 ).
   PubMedGoogle Scholar
• Maderazo EG , QuintilianiR , TiltonRC , BartlettR , JoyceNC , AndrioleVT . Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens . Antimicrob. Agents Chemother.8 ( 1 ), 54 – 57 ( 1975 ).
   PubMed Web of Science ®Google Scholar
• Kuck NA.  In vitro and in vivo activities of minocycline and other antibiotics against Acinetobacter (Herellea-Mima) . Antimicrob. Agents Chemother.9 ( 3 ), 493 – 497 ( 1976 ).
   PubMed Web of Science ®Google Scholar
• Montgomerie JZ , PickettMJ , YoshimoriRN , ChowAW , GuzeLB . Susceptibility of Acinetobacter calcoaceticus var. anitratus (Herellea vaginicola) to minocycline . Antimicrob. Agents Chemother.10 ( 1 ), 102 – 105 ( 1976 ).
   PubMed Web of Science ®Google Scholar
• Hawley JS , MurrayCK , GriffithMEet al. Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel . Antimicrob. Agents Chemother.51 ( 1 ), 376 – 378 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Tan TY , NgLS , TanE , HuangG . In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates . J. Antimicrob. Chemother.60 ( 2 ), 421 – 423 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Arroyo LA , MateosI , GonzálezV , AznarJ . In vitro activities of tigecycline, minocycline, and colistin–tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group . Antimicrob. Agents Chemother.53 ( 3 ), 1295 – 1296 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Liang W , LiuXF , HuangJ , ZhuDM , LiJ , ZhangJ . Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients . BMC Infect. Dis.11 , 109 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang Y , ChenF , SunE , MaR , QuC , MaL . In vitro antibacterial activity of combinations of fosfomycin, minocycline and polymyxin B on pan-drug-resistant Acinetobacter baumannii . Exp. Ther. Med.5 ( 6 ), 1737 – 1739 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pei G , MaoY , SunY . In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii . Microb. Drug Resist.18 ( 6 ), 574 – 577 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Rodríguez-Hernández MJ , PachónJ , PichardoCet al. Imipenem, doxycycline and amikacin in monotherapy and in combination in Acinetobacter baumannii experimental pneumonia . J. Antimicrob. Chemother.45 ( 4 ), 493 – 501 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Griffith ME , YunHC , HorvathLL , Murray CK . Minocycline therapy for traumatic wound infections caused by the multidrug-resistant Acinetobacter baumannii –Acinetobacter calcoaceticus complex . Infect. Dis. Clin. Pract.16 ( 1 ), 16 – 19 ( 2008 ).
   Google Scholar
• Jonas M , CunhaBA.  Minocycline Minocycline . Ther. Drug Monit.4 ( 2 ), 137 – 145 ( 1982 ).
   PubMed Web of Science ®Google Scholar
• Ramirez JA.  Antibiotic streamlining: development and justification of an antibiotic streamlining program . Pharm. Pract. Manag. Q.16 ( 3 ), 19 – 34 ( 1996 ).
   PubMedGoogle Scholar
• Chan JD , GravesJA , DellitTH . Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia . J. Intensive Care Med.25 ( 6 ), 343 – 348 ( 2010 ).
   PubMedGoogle Scholar
• Shi Y , XuYC , LiuY , DuW , RuiX , WangY . Cefoperazone-sulbactam plus minocycline in the treatment of extensively drug resistant Acinetobacter infections . Zhonghua Yi Xue Za Zhi92 ( 40 ), 2847 – 2850 ( 2012 ).
   PubMedGoogle Scholar